ABBOTT LABORATORIES (ABT)
US0028241000 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to ABT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 132.14. This target is 14.01% above the current price.
ABT was analyzed by 32 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ABT.
In the previous month the buy percentage consensus was at a similar level.
ABT was analyzed by 32 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-05 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-17 | Bernstein | Maintains | Outperform -> Outperform |
| 2024-10-17 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-10-17 | UBS | Maintains | Buy -> Buy |
| 2024-10-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-17 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-10-17 | Jefferies | Maintains | Hold -> Hold |
| 2024-10-14 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-10-08 | Oppenheimer | Initiate | Outperform |
| 2024-10-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-01 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-09-26 | Jefferies | Reiterate | Hold -> Hold |
| 2024-09-19 | Piper Sandler | Initiate | Overweight |
| 2024-08-22 | Citigroup | Maintains | Buy -> Buy |
| 2024-07-29 | Barclays | Maintains | Overweight -> Overweight |
| 2024-07-02 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-06-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-05-30 | Goldman Sachs | Initiate | Buy |
| 2024-05-22 | Citigroup | Maintains | Buy -> Buy |
| 2024-04-22 | Barclays | Maintains | Overweight -> Overweight |
| 2024-04-18 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-04-04 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-04-03 | Citigroup | Maintains | Buy -> Buy |
| 2024-02-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-01-26 | Barclays | Maintains | Overweight -> Overweight |
| 2024-01-25 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-01-25 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-01-25 | Citigroup | Maintains | Buy -> Buy |
| 2024-01-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-01-03 | Raymond James | Maintains | Outperform -> Outperform |